Bleak session for FTSE
FTSE investors suffered a bleak session today as heavyweight mining stocks and drug maker AstraZeneca dragged the London market into the red.
AstraZeneca shares were down more than 4% after it lost a key patent for its best-selling heartburn treatment Nexium.





